<SEC-DOCUMENT>0001354457-26-000393-index.html : 20260430
<SEC-HEADER>0001354457-26-000393.hdr.sgml : 20260430
<ACCEPTANCE-DATETIME>20260430142604
ACCESSION NUMBER:		0001354457-26-000393
CONFORMED SUBMISSION TYPE:	CERT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260430
EFFECTIVENESS DATE:		20260430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hemab Therapeutics Holdings, Inc.
		CENTRAL INDEX KEY:			0002114044
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				414241952
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CERT
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-43250
		FILM NUMBER:		26923452

	BUSINESS ADDRESS:	
		STREET 1:		101 MAIN STREET
		STREET 2:		SUITE 1220
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		45 2138 7627

	MAIL ADDRESS:	
		STREET 1:		101 MAIN STREET
		STREET 2:		SUITE 1220
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>CERT
<SEQUENCE>1
<FILENAME>COAG_8A_Cert_2114044.pdf
<TEXT>
Document 1 - file: COAG_8A_Cert_2114044.pdf

</DOCUMENT>
</SEC-DOCUMENT>